English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 91280/121421 (75%)
Visitors : 25424909      Online Users : 104
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://nccur.lib.nccu.edu.tw/handle/140.119/70087


    Title: Brain-Derived Neurotrophic Factor Enhances Bcl-xL Expression Through Protein Kinase Casein Kinase 2-Activated and Nuclear Factor Kappa B-Mediated Pathway in Rat Hippocampus
    Authors: 趙知章
    Chao, Chih Chang;Chiang,CH;Ma,YL;Lee,EH
    Contributors: 神科所
    Keywords: Bcl-xL;brain-derived neurotrophic factor;casein kinase 2;hippocampus;neuroprotection;NF-kB
    Date: 2011.05
    Issue Date: 2014-09-23 12:25:04 (UTC+8)
    Abstract: Brain-derived neurotrophic factor (BDNF) was shown to produce its neuroprotective effect through extracellular signal-regulated kinase 1/2 (ERK1/2) and phosphatidylinositol-3 kinase (PI3-K) signaling. But whether other pathways also mediate the neuroprotective effect of BDNF is less known. In this study, we found that direct administration of BDNF to rat hippocampal CA1 area dose-dependently increased the mRNA and protein levels of Bcl-xL. BDNF also increased protein kinase casein kinase II (CK2) activity and NF-kB phosphorylation at Ser529 dose-dependently. Further, transfection of the wild-type CK2a DNA to CA1 neurons increased nuclear factor kappa B (NF-kB) phosphorylation and Bcl-xL mRNA expression, whereas transfection of CK2a156A, the catalytically inactive mutant of CK2a, decreased these measures. Moreover, transfection of CK2a small interfering RNA (siRNA) blocked the enhancing effect of BDNF on NF-kB phosphorylation and Bcl-xL expression. These results were further confirmed by treatment of 4,5,6,7tetrabromobenzotriazole (TBB), a specific CK2 inhibitor. Transfection of NF-kBS529A, the dominant negative mutant of NF-kB, prevented the enhancing effect of BDNF on Bcl-xL expression. More importantly, BDNF activation of CK2 is not affected by co-administration of the ERK1/2 inhibitor, PD98059, and the PI3-K inhibitor, LY294002. These results demonstrate a novel BDNF signaling pathway and provide an alternative therapeutic strategy for the protective effect of BDNF on hippocampal neurons in vivo.
    Relation: Brain Pathology,21(2),150-162
    Data Type: article
    DOI 連結: http://dx.doi.org/10.1111/j.1750-3639.2010.00431.x
    DOI: 10.1111/j.1750-3639.2010.00431.x
    Appears in Collections:[神經科學研究所 ] 期刊論文

    Files in This Item:

    File Description SizeFormat
    150-062.pdf1079KbAdobe PDF1109View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback